BALTHASER KEVIN (Chief Financial Officer) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/3/2026ACC: 0001957554-26-000011
Officer· Chief Financial Officer
Since Mar 2026
-677.00
Net shares
Net seller
$1.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
2.38K acquired · 3.05K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.38K
Price / share
—
Trade value
—
% of position
1.3%
3/1/2026
185.75K→188.13K
Common Stock
Direct
Shares
−677.00
Price / share
$2.87
Trade value
$1.94K
% of position
0.4%
3/1/2026
188.13K→187.45K
Total
Net shares
+1.70K
Net value
-$1.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | M · Option Exercise | +2.38K | — | — | 1.3% | 185.75K | 188.13K |
| Common Stock Direct | 3/1/2026 | F · Tax Withholding | −677.00 | $2.87 | $1.94K | 0.4% | 188.13K | 187.45K |
| Total | +1.70K | -$1.94K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2.38K shares
Shares
−2.38K
Strike price
Held after
0.00
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.38K shares | 3/1/2026 | M · Option Exercise | −2.38K | — | 0.00 |